SCHEMBL8613637

SCHEMBL8613637

Fc1cc(F)c2c(c1)CCC2n1cc[nH]c1=S

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DBH P09172 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6959664 0.80 DBH (0.36) DBH
SCHEMBL8609694 0.78 DBH (0.32) DBH
SCHEMBL6958827 0.77 DBH (0.35) DBH
SCHEMBL6953857 0.75 DBH (0.35) DBH
SCHEMBL8614330 0.72 DBH (0.37) DBH
SCHEMBL6959364 0.69 DBH (0.32) DBH
SCHEMBL6957740 0.69 HTR2B (0.38) DBH
SCHEMBL2861872 0.68 DBH (0.33) DBH
SCHEMBL8612565 0.68 ESR2 (0.40) DBH
SCHEMBL8611435 0.66 DBH (0.36) DBH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO disclosed